mesozeaxanthin
Small moleculeexperimental
Meso-zeaxanthin (3R,3′S-zeaxanthin) is a xanthophyll carotenoid, and is one of the three stereoisomers of zeaxanthin. The meso- form is the second most abundant in nature, after 3R,3′R-zeaxanthin, which is produced by plants and algae. Meso-zeaxanthin has been identified in specific tissues of marine organisms and in the macula lutea, also known as the "yellow spot" of the human retina. — Wikipedia
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2017 (NCT04460365)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMeso-Zeaxanthin ↗
- WikipediaMeso-zeaxanthin ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03959592 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2019 | Duke University, Heidelberg Engineering GmbH, Industrial Orgánica S.A. de C.V., MacuHealth LP |
| NCT04460365 | N/A | Oct 1, 2017 | Centre for Eye Research Ireland |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centre for Eye Research Ireland | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Duke University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Heidelberg Engineering GmbH | For profit | 1 | 0 | 1 | 2019 |
| Industrial Orgánica S.A. de C.V. | For profit | 1 | 0 | 1 | 2019 |
| MacuHealth LP | For profit | 1 | 0 | 1 | 2019 |
5 organizations
Page 1 / 1